HBM Healthcare Investments AG Stock price

Equities

HBMN

CH0012627250

Investment Management & Fund Operators

Delayed Swiss Exchange 11:30:20 2023-09-22 am EDT Intraday chart for HBM Healthcare Investments AG 5-day change 1st Jan Change
175.40 CHF -1.90% -3.20% -12.74%
Sales 2024 * -42 M -47 M Sales 2025 * 46 M 51 M Capitalization 1 220 M 1 344 M
Net income 2024 * -71 M -78 M Net income 2025 * 18 M 20 M EV / Sales 2024 *
-28,0x
Net cash position 2024 * 32 M 35 M Net cash position 2025 * 44 M 48 M EV / Sales 2025 *
25,5x
P/E ratio 2024 *
-16,9x
P/E ratio 2025 *
72,5x
Employees -
Yield 2024 *
4,28%
Yield 2025 *
3,95%
Free-Float82.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.90%
1 week-3.20%
Current month-1.68%
1 month-3.09%
3 months-10.05%
6 months-13.38%
Current year-12.74%
More quotes
1 week
175.00
Extreme 175
181.40
1 month
173.60
Extreme 173.6
188.00
Current year
173.60
Extreme 173.6
232.50
1 year
173.60
Extreme 173.6
243.00
3 years
173.60
Extreme 173.6
367.00
5 years
140.00
Extreme 140
367.00
10 years
62.40
Extreme 62.4
367.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 2012
Director of Finance/CFO 53 2011
Corporate Secretary 59 -
Members of the board TitleAgeSince
Director/Board Member 51 2011
Chairman 67 2009
Director/Board Member 52 -
More insiders
Date Price Change Volume
23-09-22 175.40 -1.90% 3,713
23-09-21 178.80 -0.45% 2,001
23-09-20 179.60 +1.70% 3,969
23-09-19 176.60 -2.21% 4,901
23-09-18 180.60 -0.33% 3,590

Delayed Quote Swiss Exchange, September 22, 2023 at 11:30 am EDT

More quotes
HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.
Calendar
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
175.40CHF
Average target price
236.00CHF
Spread / Average Target
+34.55%
Consensus

Annual profits - Rate of surprise

  1. Markets
  2. Equities
  3. Stock HBM Healthcare Investments AG - Swiss Exchange
-40% off #SeptemberDeals : Our subscriptions help you find hidden investment opportunities.
Subscribe
fermer